for the time being Prurisol has become the side show in my mind, though eventually an important one. Understandably, people are very antsy for kevetrin P1 serum and scan data from the first cohorts. Until we get this data everything else "seems" unimportant. I know I've been on edge the last week or so. My crystal ball says one week or less, with Friday's PR about ASCO indicating Leo doesn't yet have the tabulated data.

A T L